Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB stock from hold to buy.

Shares of Aurora Cannabis Inc. ACB rose 1.21% to $5.86 Thursday, on what proved to be an all-around dismal trading session ...

Canadian cannabis stock Aurora Cannabis (TSE:ACB) is stepping up its line of offerings in Australia, and bringing a new set of pastille ...

Shares of Aurora Cannabis Inc. ACB slipped 4.28% to $6.04 Tuesday, on what proved to be an all-around positive trading ...

Dario Sabaghi covers the cannabis industry with a focus on Europe. Canadian company Aurora Cannabis has announced the launch of its first German-cultivated medical cannabis product amid the easing ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced ...

From political maneuvering in Washington to major corporate developments across the global cannabis landscape, this week has ...

ACB Agreement Complements Existing Relationship Focused on the Supply of Premium CannabisEDMONTON, AB, February 6, 2 ...

Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements ...